A comparison of the Roche Cobas® Core and Hybritech TANDEM®-E PSA (prostate specific antigen) assays revealed a large difference in the reactivity of each assay to the separated free and complexed forms of serum PSA in patients with prostatic carcinoma. The Roche assay was relatively much more responsive to the free form, but the Hybritech assay was relatively more responsive to the complexed form and total serum PSA. It is possible that the adoption of a universal standard for PSA will not completely resolve the disagreement between PSA assay on individual patient samples, and the use of separate assays for the free and complexed forms may be necessary for the further clinical development of PSA as a tumour marker.
CooperEHRobinsonMRGWhelanPFerroMA. Tumor markers in prostate cancer. Cancer1992; 70: 225–9.
3.
The Immunoassay Kit Directory. Series A: Clinical chemistry. Vol 1, Part 3. Proteins and tumour markers. Lancaster, UK: Kluwer Academic Publishers bv, 1992.
4.
GravesHCBWehnerNStameyTA. Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an International antigen standard. J Urol1990; 144: 1516–22.
5.
StenmannUHLeinonenJAlftanHRannikkoSTuhkanenKAlftanO. A complex between prostate-specific antigen and α-1 antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res1991; 51: 222–6.
6.
LiljaHCockettATKAbrahamssonPA. Prostate specific antigen predominantly forms a complex with α-1 antichymotrypsin in blood. Cancer1992; 70: 230–4.
7.
PassingHBablokW. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem1983; 21: 709–20.
8.
BlandJMAltmanDG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1986; i: 307–10.
9.
StrikePW. Statistical Methods in Laboratory Medicine. Oxford: Butterworth-Heinemann, 1991: 204–5.
10.
ZhouATewariPBonacciMWalshRLarsenFStameyTComplexation of prostate specific antigen (PSA) in serum. Clin Chem1992; 38: 982.
11.
ColeLAKardanaA. Discordant results in human chorionic gonadotrophin assays. Clin Chem1992; 38: 263–70.
12.
HentuPLikkarinenOVikhoP. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int J Cancer1990; 45: 654–60.
